EA200301045A2 - Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции - Google Patents

Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции

Info

Publication number
EA200301045A2
EA200301045A2 EA200301045A EA200301045A EA200301045A2 EA 200301045 A2 EA200301045 A2 EA 200301045A2 EA 200301045 A EA200301045 A EA 200301045A EA 200301045 A EA200301045 A EA 200301045A EA 200301045 A2 EA200301045 A2 EA 200301045A2
Authority
EA
Eurasian Patent Office
Prior art keywords
production
pharmaceutical compositions
compositions containing
imidazoline derivatives
optionally substituted
Prior art date
Application number
EA200301045A
Other languages
English (en)
Other versions
EA200301045A3 (ru
EA006197B1 (ru
Inventor
Сильвен Рольт
Марина Копп
Жан-Шарль Ланселот
Стефан Леметр
Даниель-Анри Кэньяр
Жан-Ги Бизо-Эспиар
Пьер Ренар
Original Assignee
Ле Лаборатур Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатур Сервье filed Critical Ле Лаборатур Сервье
Publication of EA200301045A2 publication Critical patent/EA200301045A2/ru
Publication of EA200301045A3 publication Critical patent/EA200301045A3/ru
Publication of EA006197B1 publication Critical patent/EA006197B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Соединения формулы (I)где Rпредставляет собой необязательно замещенную гетероарильную группу,Rпредставляет собой необязательно замещенную циклоалкильную группу,Rпредставляет собой атом водорода или алкильную группу иRи Rявляются такими, как указано в описании,их энантиомеры, диастереизомеры и таутомеры, а также их соли присоединения фармацевтически приемлемой кислоты или основы. Лекарственные средства.
EA200301045A 2002-10-23 2003-10-22 Производные имидазолина, способ их получения и содержащие их фармацевтические композиции EA006197B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213194A FR2846328B1 (fr) 2002-10-23 2002-10-23 Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (3)

Publication Number Publication Date
EA200301045A2 true EA200301045A2 (ru) 2004-04-29
EA200301045A3 EA200301045A3 (ru) 2004-08-26
EA006197B1 EA006197B1 (ru) 2005-10-27

Family

ID=29763935

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301045A EA006197B1 (ru) 2002-10-23 2003-10-22 Производные имидазолина, способ их получения и содержащие их фармацевтические композиции

Country Status (25)

Country Link
US (2) US6875788B2 (ru)
EP (1) EP1413579B1 (ru)
JP (1) JP2004143167A (ru)
KR (1) KR100642844B1 (ru)
CN (1) CN1234694C (ru)
AR (1) AR041688A1 (ru)
AT (1) ATE288432T1 (ru)
AU (1) AU2003257606A1 (ru)
BR (1) BR0304634A (ru)
CA (1) CA2445817A1 (ru)
DE (1) DE60300307T2 (ru)
DK (1) DK1413579T3 (ru)
EA (1) EA006197B1 (ru)
ES (1) ES2236672T3 (ru)
FR (1) FR2846328B1 (ru)
HK (1) HK1063320A1 (ru)
MA (1) MA27013A1 (ru)
MX (1) MXPA03009576A (ru)
NO (1) NO20034722L (ru)
NZ (1) NZ529084A (ru)
PL (1) PL363022A1 (ru)
PT (1) PT1413579E (ru)
SG (2) SG113482A1 (ru)
SI (1) SI1413579T1 (ru)
ZA (1) ZA200308265B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3214296A1 (en) * 2021-07-08 2023-01-12 China Petroleum & Chemical Corporation Application of naphthenic imidazoline in inhibiting formation of natural gas hydrates and composition containing same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES363246A0 (es) * 1968-02-09 1971-01-16 Scherico Ltd Un procedimiento para preparar nuevas amidinas ciclicas.
US3932431A (en) * 1970-06-24 1976-01-13 Schering Corporation Certain 2-[α(2-pyridyl)-benzyl] imidazolines and derivatives thereof
US4081544A (en) * 1975-12-04 1978-03-28 Schering Corporation Certain 2-(alpha(2-pyridyl)-benzyl)imidazolines and derivatives thereof
CA1330663C (en) * 1987-10-19 1994-07-12 John Michael Berge Thiazolidinedione derivatives
GB8916150D0 (en) * 1989-07-14 1989-08-31 Beecham Group Plc Novel compounds
GB9123857D0 (en) * 1991-11-09 1992-01-02 Smithkline Beecham Plc Novel compounds
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JP3416141B2 (ja) * 1994-02-04 2003-06-16 アイシー・ワン・インコーポレイテッド 奨励クレジットの割当て及び割戻し方法及び装置
CA2180891C (en) * 1995-07-12 2010-01-12 Junichi Rekimoto Notification of updates in a three-dimensional virtual reality space sharing system
US5937391A (en) * 1996-07-11 1999-08-10 Fujitsu Limited Point-service system in online shopping mall
US5926179A (en) * 1996-09-30 1999-07-20 Sony Corporation Three-dimensional virtual reality space display processing apparatus, a three-dimensional virtual reality space display processing method, and an information providing medium
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
US20050203835A1 (en) * 1998-01-30 2005-09-15 Eli Nhaissi Internet billing
GB2351081A (en) * 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
US7037194B2 (en) * 2000-03-23 2006-05-02 Atlantic City Coin & Slot Service Company, Inc. Method and device for playing a game
US6672961B1 (en) * 2000-03-16 2004-01-06 Sony Computer Entertainment America Inc. Computer system and method of displaying images
US7383223B1 (en) * 2000-09-20 2008-06-03 Cashedge, Inc. Method and apparatus for managing multiple accounts
US20030118575A1 (en) * 2001-12-11 2003-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Method for administering BIRB 796 BS
US20050235008A1 (en) * 2002-08-01 2005-10-20 Walt Camping Apparatus and method for collateral recovery
US20050177492A1 (en) * 2002-08-01 2005-08-11 Walt Camping Apparatus and method for asset tracking and recovery
US20050137904A1 (en) * 2003-10-14 2005-06-23 Kathleen Lane System and method for monitoring secured liens
US7882023B2 (en) * 2004-06-23 2011-02-01 Paul Parrish Method and system for managing collateral or property risk in a secured loan or lease portfolio
US7055740B1 (en) * 2004-12-06 2006-06-06 Target Brands, Inc. Stored-value card adapted to be read by an electronic device

Also Published As

Publication number Publication date
SG113482A1 (en) 2005-08-29
EP1413579B1 (fr) 2005-02-02
KR100642844B1 (ko) 2006-11-10
US20040087638A1 (en) 2004-05-06
CN1496982A (zh) 2004-05-19
DE60300307D1 (de) 2005-03-10
SI1413579T1 (en) 2005-06-30
CN1234694C (zh) 2006-01-04
PT1413579E (pt) 2005-05-31
JP2004143167A (ja) 2004-05-20
AU2003257606A1 (en) 2004-05-13
ES2236672T3 (es) 2005-07-16
HK1063320A1 (en) 2004-12-24
AR041688A1 (es) 2005-05-26
CA2445817A1 (fr) 2004-04-23
DE60300307T2 (de) 2006-01-19
NO20034722L (no) 2004-04-26
KR20040036590A (ko) 2004-04-30
FR2846328B1 (fr) 2004-12-10
DK1413579T3 (da) 2005-05-09
ATE288432T1 (de) 2005-02-15
MA27013A1 (fr) 2004-12-20
NZ529084A (en) 2005-04-29
SG127755A1 (en) 2006-12-29
US6875788B2 (en) 2005-04-05
BR0304634A (pt) 2004-06-01
EA200301045A3 (ru) 2004-08-26
US20050143440A1 (en) 2005-06-30
PL363022A1 (en) 2004-05-04
EP1413579A1 (fr) 2004-04-28
FR2846328A1 (fr) 2004-04-30
NO20034722D0 (no) 2003-10-22
EA006197B1 (ru) 2005-10-27
MXPA03009576A (es) 2004-04-29
ZA200308265B (en) 2004-07-09

Similar Documents

Publication Publication Date Title
DE60130771D1 (de) Substituierte heterocyclische amide
EA200601235A1 (ru) Производные тиазола
HUT53361A (en) Process for producing 2-(1-piperazinyl)-4-phenyl cycloalkanopyridine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE60128343D1 (de) Pyrimidine verbindungen
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
EA200300982A1 (ru) Гетероциклические производные для лечения рака и других пролиферативных заболеваний
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EA200500717A1 (ru) Новые соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат
EA200500690A1 (ru) Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат
ATE276257T1 (de) Pyrazinonderivate
PT1216245E (pt) Derivados sulfonil-hidrazida farmaceuticamente activos
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
EA200301045A3 (ru) Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции
EA200501696A1 (ru) Новые соединения тиадиазина, способ их получения и фармацевтические композиции, которые их содержат
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
NZ543068A (en) Substituted 4-(alkyl-amide)-piperidine derivatives, processes for their preparation, and pharmaceutical compositions containing them
EA200000374A3 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
EA200000373A3 (ru) Новые соединения 1-аза-2-алкил-6-арилциклоалкана, способ их получения и содержащие их фармацевтические композиции
DE60335960D1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
EA200200563A1 (ru) Новые соединения инденоиндолона, способ их получения и фармацевтические композиции, их содержащие
EA200100344A2 (ru) Новые циклобутаиндолкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции